Mangalam Drugs & Organics Bulk Deal: Vijay Kedia has bought Rs. 48 lakh sold 1.38 lakh shares

Microcap stock Mangalam Drugs & Organics saw bulk deals on Wednesday, with Vijay Kedia’s investment firm Kedia Securities Pvt Ltd adding Rs. Around 1.38 lakh shares worth Rs 48.35 lakh were sold.

Other sellers included Neo Apex Venture LLP (Rs 27.6 lakh), Epitom Trading and Investments (Rs 42 lakh) and Multiplier Share and Stock Advisors Pvt Ltd (Rs 44 lakh).

Shares of Mangalam Drugs rose 5% on the NSE today to Rs. was settled at 35.18.

Also Read: Ashish Kacholia buys 2.9% stake in smallcap AdCounty Media. Stock down 60% from peak

Mangalam Drugs, a Gujarat-based company, started manufacturing active pharmaceutical ingredients (APIs) and intermediates in 1977. It has multi-product manufacturing facilities at two locations and an in-house research and development laboratory.

Mangalam Drugs share price has fallen 69% in the last 12 months. But the stock has seen significant buying action in the past month, with the stock jumping nearly 40%.

Despite the late rally, according to Trendline data, the company’s shares traded at Rs. 39.6 and Rs. are trading below their 50-day and 200-day simple moving averages (SMA) of 69.3.

Also Read: Ramakrishna Forging’s bulk deal: Morgan Stanley signs Rs. 95 crore shares were bought

This rally has pushed the counter strongly into the overbought zone and the day’s MFI has suggested levels around 90. A number above 70 is considered overbought while a number below 30 is seen as oversold.

For the quarter ended September 30, 2025, the company posted Rs. 7.4 crore, compared to Rs. 2.7 crore as against a profit after tax (PAT) of Rs. Total revenue in the quarter under review was Rs. 50 crore was recorded, which was higher than the Rs. 80 crore is 38% lower.

(Disclaimer: Recommendations, suggestions, opinions and views given by experts are their own. These do not represent the views of Economic Times.)